Abstract
Retigabine (Fig. 1) corresponds chemically to ethyl N-[2-amino-4-[(4fluorophenyl)methylamino]phenyl] carbamate with an empirical formula of C16H18FN3O2 and a molecular weight of 303.33.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ferron GM, Sachdeo R, Partiot A, Fritz T, Althouse S, Troy SM. Pharmacokinetic interaction between valproic acid, topiramate, phenytoin or carbamazepine and retigabine in epileptic patients. Clin Pharmacol Ther. 2001;6 (Suppl) 2:18.
Hermann R, Knebel NG, Niebch G, Richards L, Borlak J, Locher M. Pharmacokinetic interaction between retigabine and lamotrigine in healthy subjects. Eur J Clin Pharmacol. 2003;58:795–802.
Ferron GM, Pata A, Parks V, Rolan P, Troy SM. Lack of pharmacokinetic interaction between retigabine and phenobarbitone at steady-state in healthy subjects. Br J Clin Pharmacol. 2003;56:39–45.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag London
About this chapter
Cite this chapter
Patsalos, P.N. (2013). Retigabine. In: Antiepileptic Drug Interactions. Springer, London. https://doi.org/10.1007/978-1-4471-2434-4_19
Download citation
DOI: https://doi.org/10.1007/978-1-4471-2434-4_19
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-2433-7
Online ISBN: 978-1-4471-2434-4
eBook Packages: MedicineMedicine (R0)